Temoside 20mg

Temoside 20 is a medication used to treat certain types of brain cancer, including glioblastoma and anaplastic astrocytoma. It is an oral chemotherapy medication that works by stopping the growth of cancer cells. Here are some key points about the product:

Composition:

Temoside 20 contains Temozolomide, a chemotherapy medication that is used to treat brain cancer.

Indications:

Temoside 20 is indicated for the treatment of:

1. Glioblastoma (brain cancer) in adults
2. Anaplastic astrocytoma (brain cancer) in adults

Mechanism of Action:

Temozolomide works by:

1. Inhibiting the production of thymidine, a nucleotide that is necessary for the growth of cancer cells
2. Inhibiting the repair of DNA damage, which can lead to cell death

Dosage and Administration: The recommended dosage of Temoside 20 is:

• 20mg/kg administered as a capsule once daily for 5 days
• The dose should be repeated every 28 days

Side Effects:

Common side effects of Temoside 20 include:

1. Nausea and vomiting
2. Fatigue
3. Hair loss
4. Headache
5. Dizziness
6. Constipation
7. Diarrhea
8. Increased risk of infections

Serious side effects can include:

1. Bone marrow suppression (reduced production of blood cells)
2. Increased risk of bleeding or bruising
3. Infections
4. Allergic reactions
5. Lung or liver damage

Contraindications:

Temoside 20 is contraindicated in patients with:

1. Hypersensitivity to Temozolomide
2. Pregnancy or breastfeeding
3. Severe kidney or liver disease

Precautions:

1. Patients with a history of kidney or liver disease should be closely monitored while receiving Temoside 20.
2. Patients with a history of bone marrow suppression should be closely monitored while receiving Temoside 20.
3. Patients with a history of infections should be closely monitored while receiving Temoside 20.

Patient Counseling:

• Patients should be counseled on the importance of taking their medication as directed and not missing doses.
• Patients should be instructed to report any signs of nausea or vomiting.
• Patients should be advised to report any changes in their appetite or weight loss.

Storage and Handling:

• Store at room temperature (20°C to 25°C) and protected from light.
• Do not freeze or expose to direct sunlight.
• Use within 24 months of opening.

Please note that the dosage and administration information is based on the recommended dosage and may vary depending on individual patient needs and circumstances.